Start-Up Quarterly Statistics, Q2 2014

During the second quarter of 2014 start-up companies raised a total of $893.9 million, a 25% drop from the previous quarter’s $1.18 billion, which was the biggest quarter for start-up fundraising since this column debuted five years ago. Biopharma companies garnered 88% ($779.6 million), the most (40%) resulting from Series B rounds. Only four medical device start-ups raised money, a total of $68.4 million, and four in vitro diagnostics companies took in a combined $45.9 million, almost doubling Q1’s $23.1 million. (See Exhibit 1.)